OnePin Peptide Library · Repair & Recovery
BPC-157 Arginate
BPC-157 Arginate Salt
BPC-157 Arginate (also called BPC-157 Arginine Salt) is a stable salt form of the gastric pentadecapeptide BPC-157, where the peptide is complexed with L-arginine. This formulation was developed to improve the stability and oral bioavailability of BPC-157, as the arginine salt form is more resistant to degradation in the gastrointestinal tract.
Same timing as standard BPC-157. Can be taken any time. Empty stomach for oral dosing.
Start here. Every protocol below is ordered lowest-first. Begin at the smallest effective dose, hold about a week to assess tolerance, and step up only if needed.
How it works
Identical mechanism to standard BPC-157: upregulates VEGF and eNOS for angiogenesis, modulates the NO system, promotes FAK-paxillin pathway for cell migration, and increases GH receptor expression. The arginine salt form provides a counterion that stabilizes the peptide structure, particularly in low-pH environments like the stomach. Arginine itself is a nitric oxide precursor, which may provide a minor additive benefit to BPC-157's own NO-modulating effects.
Identical mechanism to standard BPC-157: upregulates VEGF and eNOS for angiogenesis, modulates the NO system, promotes FAK-paxillin pathway for cell migration, and increases GH receptor expression. The arginine salt form provides a counterion that stabilizes the peptide structure, particularly in low-pH environments like the stomach. Arginine itself is a nitric oxide precursor, which may provide a minor additive benefit to BPC-157's own NO-modulating effects.
What to expect
Days 1-7: Reduced inflammation and pain at injury site. Gut issues may show early improvement. Same rapid onset as standard BPC-157.
Evidence
The honest take
Arginate form is significantly better than standard BPC-157
Partly truePartially supported. The arginate salt form does show improved acid stability, which is meaningful for oral administration. For injectable use, the difference is likely negligible since both forms deliver the same active peptide into the bloodstream.
Overstated. Standard BPC-157 (acetate) is already acid-stable due to its amino acid sequence. The arginate form may provide incrementally better oral bioavailability, but standard BPC-157 has extensive oral efficacy data in animal studies.
Interactions & stacking
What's safe to combine, and what belongs in a separate pin.
Safe & synergistic
Keep separate
Side effects & safety
Commonly reported
- Mild injection site redness (resolves quickly)
- Occasional lightheadedness post-injection
- Mild GI changes during gut healing phase
Less common & notes
- Same exceptionally favorable safety profile as standard BPC-157.
- No LD50 established in animal studies.
- Long-term human safety data does not exist for either form.
Pharmacokinetics
Storage. Reconstitute with bacteriostatic water for injection. Store refrigerated at 2-8C. Same stability as standard BPC-157 - 28-30 days after reconstitution. For oral use, some users dissolve in water and drink. Do not freeze after reconstitution.
Regulatory status
Not FDA-approved for any indication. Same regulatory status as standard BPC-157 - available through compounding pharmacies and research suppliers. All human use is experimental/off-label.
Put it to work
Calculate, log & track
Open BPC-157 Arginate straight into OnePin with your vial and dose pre-filled, then let it handle the syringe math and remind you before the vial runs out.
Open BPC-157 Arginate in the app →Go deeper
The guide & community
The complete BPC-157 Arginate walkthrough, real protocol discussion and coaching live inside the BlessUp community on Skool.
Join the community ↗